Please login to the form below
IAPT
This page shows the latest IAPT news and features for those working in and with pharma, biotech and healthcare.
NICE backs trial of online and mobile depression programme
Deprexis will now undergo a two-year trial as part of NHS England’s Improving Access to Psychological Therapies (IAPT) programme.
Latest news
-
NICE to bring HTA processes to mobile health apps
NHS England's cognitive behavioural programme Improving Access to Psychological Therapies ( IAPT) in particular is tipped to benefit from the briefings, as the NICE-evaluated apps grow to establish a foundation
-
More money for talking therapies to target mental health
The NHS will be given £170m to set-up the improving access to psychological therapies (IAPT) programme and recruit 3, 600 extra staff. ... With government ministers hoping to decrease the number of people on incapacity benefit and raise the level of
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
What is changing in mental health and dementia care?
dementia. Adult mental health. The Long-term Plan says thataccess to psychological therapies (IAPT) services will continue to expand so that 1.5m people will be able to access treatment each
-
A new vision for tackling key illnesses
pupils. The NHS promises to continue to expand access to IAPT services for adults and older adults with common mental health problems, with a focus on those with long-term conditions.
-
How can pharma help the NHS drive much-needed change in mental health services?
Changes that could help to achieve PoE . Early intervention is key and GPs should be looking to refer patients to services such as Improving Access to Psychological Therapies (IAPTs) - a
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
- Gut instincts lead Takeda to GI pipeline success
- How will the events and exhibitions industry change post-Coronavirus?
- China’s CanSino Biologics reveals phase 2 coronavirus vaccine results
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- Roche’s Tecentriq combo scores FDA approval for melanoma
- Socially distanced strategising
- Artificial Intelligence in Digital Therapeutics
- Virtual Reality in Medicine and Clinical Research
- J&J inks $1bn deal with US for coronavirus vaccine
- Novartis builds its case for novel MS treatment ofatumumab
- Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer
PMHub
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
